The Food and Drug Administration ("FDA") expands informed consent exceptions with a final rule permitting institutional review board ("IRB") waiver or alteration of ...

IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites IRB approval from Hadassah Medical Center follows Clearmind’s prior regulatory ...

PRINCETON, N.J. & OVERLAND PARK, Kan.--(BUSINESS WIRE)--WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the ...

“Receiving the IRB approval from Yale University, takes us one step closer to commencing our innovation clinical trial with our proprietary CMND-100, for treating AUD patients,” said Dr. Adi ...

Nexalin Technology, Inc. has announced that it has received Institutional Review Board approval from the University of California, San Diego for clinical testing of its HALO™ Clarity headset, which ...

PITTSBURGH--(BUSINESS WIRE)--Apollo Neuroscience TM, makers of the first scientifically-validated wearable that improves the body’s resilience to stress, is running an IRB-approved clinical trial with ...

Company reaches next clinical trial milestone for the intramuscular treatment of Chronic Lower Back Pain with the first novel allogenic cellular therapy in the United States PHOENIX, Oct. 10, 2023 ...

ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent Institutional Review Board's (IRB) acceptance of its initial draft protocol and invitation to submit a final version, ...

Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development ...

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development ...

IRB Approval from Hadassah Medical Center Follows FDA IND Clearance and Prior Approvals from Additional Clinical Sites Vancouver, Canada, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.